(Q33645634)

28 July 2017

title

Lithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depression (English)

1 reference

Bruno Müller-Oerlinghausen

28 July 2017

0 references

1 reference

series ordinal

2

object named as

Bruno Müller-Oerlinghausen

1 reference

28 July 2017

author name string

Mohammed T Abou-Saleh

series ordinal

1

1 reference

28 July 2017

Alec J Coppen

series ordinal

3

1 reference

28 July 2017

publication date

8 May 2017

1 reference

International journal of bipolar disorders

28 July 2017

published in

1 reference

28 July 2017

volume

5

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

11

1 reference

Creative Commons Attribution 4.0 International

28 July 2017

copyright license

start time

8 May 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Suicides and Suicide Attempts during Long-Term Treatment with Antidepressants: A Meta-Analysis of 29 Placebo-Controlled Studies Including 6,934 Patients with Major Depressive Disorder

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Pharmacologic approaches to treatment resistant depression: Evidences and personal experience

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

The suicide prevention effect of lithium: more than 20 years of evidence-a narrative review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Does lithium reduce acute suicidal ideation and behavior? A protocol for a randomized, placebo-controlled multicenter trial of lithium plus Treatment As Usual (TAU) in patients with suicidal major depressive episode.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Mood Spectrum Model: Evidence reconsidered in the light of DSM-5

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Lithium for post-electroconvulsive therapy depressive relapse prevention: a consideration of the evidence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Lithium in the treatment of major depressive disorder

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Attributable risk of psychiatric and socio-economic factors for suicide from individual-level, population-based studies: a systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Lithium treatment reduces suicide risk in recurrent major depressive disorder

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Lithium versus antidepressants in the long-term treatment of unipolar affective disorder

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

What happened to lithium? Antidepressant augmentation in clinical settings

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

The treatment gap in mental health care

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Lithium for maintenance treatment of mood disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Lithium in unipolar depression and the prevention of suicide.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

The course of monopolar depression and bipolar psychoses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Double-blind and open prospective studies on lithium prophylaxis in affective disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Prophylactic lithium in affective disorders. Controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Psychopathology, temperament, and past course in primary major depressions. 1. Review of evidence for a bipolar spectrum

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Lithium treatment and prophylaxis in unipolar depression: a meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40345-017-0080-X

Lithium Treatment Reduces Suicide Risk in Recurrent Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40345-017-0080-X

Differences in incidence of suicide attempts between bipolar I and II disorders and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40345-017-0080-X

Atypical features in depression: Association with obesity and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40345-017-0080-X

The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40345-017-0080-X

Lithium in bipolar and other affective disorders: prescribing practice in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40345-017-0080-X

A 5-year prospective study of predictors for functional and work disability among primary care patients with depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40345-017-0080-X

Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40345-017-0080-X

Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS40345-017-0080-X

[Antidepressant-resistant depression and the bipolar spectrum -- diagnostic and therapeutic considerations].

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

What Happened to Lithium? Antidepressant Augmentation in Clinical Settings

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Depression as a lethal disease: prevention strategies.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5420548

Prophylactic lithium in recurrent affective disorders

30 October 2018

1 reference

12 December 2020

Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis

1 reference

12 December 2020

The course of affective disorders

1 reference

12 December 2020

Classification of Depression and Response to Antidepressive Therapies

1 reference

12 December 2020

Who responds to prophylactic lithium?

1 reference

12 December 2020

Pharmacological choices after one antidepressant fails: a survey of UK psychiatrists

1 reference

12 December 2020

How long should drug therapy for depression be maintained?

1 reference

12 December 2020

Lithium therapy: from clinical trials to practical management

1 reference

12 December 2020

Relapse in delusional depression: a retrospective study of the course of treatment

1 reference

12 December 2020

Lithium continuation therapy following electroconvulsive therapy

1 reference

12 December 2020

Lithium in the Prophylaxis of Unipolar Depression: A Review1

1 reference

12 December 2020

Suicide mortality in patients on lithium maintenance therapy

1 reference

12 December 2020

Five-year outcome for maintenance therapies in recurrent depression

1 reference

12 December 2020

Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients

1 reference

12 December 2020

Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis

1 reference

12 December 2020

Is delusional depression related to bipolar disorder?

1 reference

12 December 2020

A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation

1 reference

12 December 2020

Heterogeneity in psychotic depression

1 reference

12 December 2020

Imipramine with electrical treatment in depression--a controlled trial

1 reference

12 December 2020

Prophylactic medication for unipolar depressive illness: the place of lithium carbonate in combination with antidepressant medication

1 reference

12 December 2020

Continuation Therapy with Antidepressants After Electroconvulsive Therapy

1 reference

12 December 2020

Subtypes of depression. Family study perspective

1 reference

12 December 2020

Does lithium exert an independent antisuicidal effect?

1 reference

12 December 2020

10.1186/S40345-017-0080-X

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference